Under the leadership of Professor Johann de Bono, we are seeking to appoint a Assistant Study Manager to join The Drug Development Unit (DDU), within the ICR and Royal Marsden. DDU undertakes industry-sponsored early phase clinical trials of new anticancer drugs. We are a world class clinical trials unit with a dedicated ward within the Royal Marsden Hospital for the development of novel cancer therapeutics which we believe will improve the care of cancer patients.
Key Requirements
The post holders will be educated to at least degree level in life sciences/nursing, with experience of working in Phase I Oncology clinical trials, preferably with experience of having contact with patients with terminal disease. They must have excellent communication and customer service skills to ensure highly effective and appropriate communication both with patients and their families/carers, member of the multidisciplinary research team and with external partners. They must have a sound working knowledge of the regulatory framework underpinning UK Clinical Trials and the implementation of clinical trial protocols in accordance ICH GCP within an investigator site.
The post holder must be highly organised and able to assist our Study Management team with managing several highly complex studies at a time, planning their work and competing priorities around a busy clinical unit. They should be logical and methodical, possess strong problem solving skills and be proficient in the use of MS Office applications.
Appointments will be on a one-year contract in the first instance. This post also benefits from generous annual leave entitlement and a pension.
To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and with your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Due to the high volumes of applications we receive, we reserve the right to close the advert before the published closing date once we have received a sufficient number of applications. Therefore we advise that you to submit your application, as early as possible to avoid disappointment.
Department/Directorate Information
The Drug Development Unit is led by Professor Johann de Bono, comprises of clinicians, scientists, data and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets.